Headlines

заголовки анонсы
14.07.2026
01:15 9to5google.com Samsung Health will delete your data unless you hand it over for AI training

As its new redesign rolls out, Samsung Health is also forcing users into a choice – let their data be used for AI training, or make it effectively unusable in the long term.

Скрыть анонс
13.07.2026
23:02 MedicalDaily.com The Longevity Drug Thousands Are Taking Off-Label: What Science Really Says About Rapamycin

Low-dose rapamycin has extended lifespan in mice more consistently than any other compound. The first major human trial completed in 2025. Here is an honest, evidence-based account of what we know — and the significant gap that still exists.

Скрыть анонс
21:16 MedicalDaily.com Can Removing "Zombie Cells" Slow Aging? Human Clinical Trials Are Starting to Deliver Answers

Senolytics — drugs that selectively eliminate senescent cells — have moved from mouse experiments to human clinical trials across kidney disease, Alzheimer's, and frailty. Here is an honest account of what 80-plus trials are finding.

Скрыть анонс
20:46 MedicalXpress.com Can AI help make medical records less biased? New study suggests yes—with caveats

Large language models can identify judgmental language in clinical notes, but the settings play a major role in accuracy.

Скрыть анонс
20:20 News-Medical.Net New approach accurately predicts lung cancer mutations

Scientists have developed a new method for accurately predicting gene changes that cause lung cancer, without the need for slower, more expensive lab techniques.

Скрыть анонс
19:52 MedicalXpress.com Regenerating tissues may rebuild order by amplifying tiny cell differences

FMI researchers and their collaborators have shown how regenerating intestinal tissue turns small initial differences between cells into stable patterns. The findings reveal a general principle for how tissues rebuild order after injury, with possible implications for regenerative medicine.

Скрыть анонс
19:52 News-Medical.Net New genetic reference map accelerates human stem cell research

A team led by bioengineers at the University of California San Diego has developed a genome-scale reference map that details how individual genes control the functions and identities of human stem cells.

Скрыть анонс
18:20 Bioengineer.org Insilico Medicine and CMS Expand AI Collaboration for CNS Disease Research

Shanghai-based Insilico Medicine and China Medical System Holdings Limited (CMS) have intensified their collaborative efforts in the realm of AI-driven drug discovery, this time focusing on central nervous system (CNS) disorders. This fresh partnership leverages Insilico’s advanced generative artificial intelligence platform alongside CMS’s seasoned R&D and commercialization expertise to accelerate the pipeline development of innovative […]

Скрыть анонс
17:48 Зерно Онлайн Пшеница CRISPR разрешена к продаже в Великобритании

Пшеница CRISPR разрешена к продаже в Великобритании

Скрыть анонс
17:41 Phys.org 2.5 million stem cells reveal first genome-scale guide to gene function

A team led by bioengineers at the University of California San Diego has developed a genome-scale reference map that details how individual genes control the functions and identities of human stem cells. This open-access resource could help researchers build virtual cell models for complex diseases, as well as design patient-specific treatments for these diseases.

Скрыть анонс
17:39 Bioengineer.org Universal 6iL/E4 System Enables Stem Cell Growth Across Mammals

A groundbreaking advance in stem cell research has emerged with the development of a universal culture system capable of deriving and maintaining embryonic stem cells (ESCs) from a broad array of mammalian species. This innovative system, termed 6iL/E4, promises to overcome species-specific limitations that have long hindered cross-species stem cell studies, opening new frontiers in […]

Скрыть анонс
17:26 MedicalXpress.com Young blood stem cells rejuvenate aging immune systems in old mice

By freezing your own healthy blood stem cells in your 20s, thawing them and undergoing a stem cell transplant in your 40s or 50s, it might be possible to rejuvenate your blood-forming and immune systems. Science fiction? At least it works when old mice receive healthy blood stem cells from young mice.

Скрыть анонс
16:08 Phys.org Chitosan-based hydrogel membranes as transparent biomaterials for skin regeneration

IMDEA Materials Institute has developed mechanically tunable hydrogel membranes that closely mimic the mechanical environment of human skin while remaining highly biocompatible, representing an improved platform for skin tissue engineering and regenerative medicine.

Скрыть анонс
16:07 Medscape.Com Does Cancer Death Risk Increase After Transplantation?

De novo cancer may double the risk for long-term mortality among solid organ transplantation recipients, a population-based study shows.

Скрыть анонс
15:04 Yahoo.com Business FDA clears Zeta Surgical’s robotic TMS navigation system

Скрыть анонс
15:00 News-Medical.Net Robot-guided surgery successfully drains multiple deep brain abscesses

Brain abscesses located deep within the brain can rapidly become life-threatening and are often difficult to treat through conventional surgery. Brain abscesses located deep within the brain can rapidly become life-threatening and are often difficult to treat through conventional surgery.

Скрыть анонс
14:46 BioTecnika.org New CRISPR Method Helps Scientists Control Protein Production in Cells

CRISPR Flips a Hidden Switch Inside Human Cells Scientists have developed a powerful new technique to control protein production, a key process behind growth, development, and cancer. Researchers have created a novel method using CRISPR which can control the production of proteins in the cells. The research can give scientists more critical insights into cell […] The post New CRISPR Method Helps Scientists Control Protein Production in Cells appeared first on BioTecNika.

Скрыть анонс
14:08 Technology.org How AI in Medical Imaging Analysis Is Transforming Healthcare

Artificial intelligence has rapidly evolved from an emerging technology into an essential part of everyday life. From business

Скрыть анонс
13:18 South China Morning Post China’s drug industry pivots to AI-powered candidates to drive next wave of deals

After China’s cross-border deals for innovative drugs hit a record US$110 billion in the first half of 2026, the sector is now pivoting towards artificial intelligence-powered candidates to drive the next wave of transactions. China accounted for about 30 per cent of all new drugs currently under development worldwide, ranking second globally, according to Lan Gongtao, deputy director general of the Department of Drug Registration at the National Medical Products Administration. China’s...

Скрыть анонс
12:12 IbTimes.co.uk Meta Killed Its Creepy AI Photo-Cloning Tool But Instagram Users Still Cannot Block Some Data Use

Meta has withdrawn its AI image tool following privacy concerns and backlash led by a Hollywood union, highlighting the risks of automatic enrolment and synthetic image creation from public profiles.

Скрыть анонс
10:14 Technology.org Stem Cell scientists engineer “synthetic organizer” cells to improve kidney organoids

Mapping the human kidney, researchers discovered an unrecognized developmental axis and engineered “synthetic organizer” cells to recreate key

Скрыть анонс
07:41 Arxiv.org CS Tokenizer Transplantation: Mitigating Autoregressive Collapse in Edge-Efficient Bengali ASR

arXiv:2607.09598v1 Announce Type: new Abstract: Lightweight speech recognition models are critical for edge deployment, yet highly optimized architectures like Moonshine often fail on morphologically rich, non-Latin languages such as Bengali. This study identifies the root cause of this failure as the model's English-centric byte-level tokenizer, which fragments Bengali words into high-fertility byte chains and triggers catastrophic autoregressive collapse during inference. To resolve this, a novel vocabulary transplantation pipeline is proposed to replace the decoder vocabulary with the native-script BanglaBERT WordPiece vocabulary and resize the corresponding token embedding matrix. Experimental results demonstrate a reduction in token fertility from 9.16 to 1.30. By decreasing autoregressive sequence length by 85.8%, decoding instability is entirely mitigated. When evaluated on the 882-hour Lipi-Ghor dataset, the modified architecture achieves a competitive 21.54% Word Error Rate

Скрыть анонс
07:41 Arxiv.org CS LLMs for health: Perceived benefits, risks, intention to use AI chatbots, and willingness to self-disclose across sensitive health topics

arXiv:2607.09253v1 Announce Type: new Abstract: AI chatbots are increasingly used for answering health-related questions. This study examines the role of topic type discussed with an AI chatbot and individual characteristics on perceived benefits and risks, intention to use an AI chatbot, and willingness to self-disclose health information. We conducted an online experiment with a 2 (topic type: physical versus psychological, between-subjects) x 2 (topic sensitivity: low versus high, within-subjects) mixed design among a Dutch representative sample (N = 1,388). Results showed that perceived benefits were positively associated with intention and willingness to self-disclose, while perceived risks were negatively associated. Moreover, participants reported higher usage intentions for low-sensitive topics compared to high-sensitive topics. Furthermore, perceptions, intention, and willingness to self-disclose varied by individual characteristics. Overall, our findings suggest that

Скрыть анонс
07:06 DigitalTrends.com Scammers are now cloning trusted news websites to steal your money

Cybercriminals are cloning trusted news websites using AI-generated content to promote fake investment schemes, making it harder than ever to distinguish legitimate journalism from scams.

Скрыть анонс
05:36 News-Medical.Net New benchmark shows AI still misses the human side of mental health care

PsyEval is a new benchmark that tests how large language models perform on mental health knowledge, diagnostic assessment, and emotional support tasks. The study found that leading models can show strong factual recall and fluent responses, but still struggle with empathy, clinical nuance, prompt sensitivity, and safe diagnostic behavior.

Скрыть анонс
02:58 IbTimes.co.uk Senator Mitch McConnell's Latest Photo Fuels AI Rumours Following Medical Emergency

A photo of Mitch McConnell in hospital has sparked controversy, with accusations of AI manipulation and concerns over his health's political implications.

Скрыть анонс
12.07.2026
17:02 SlashGear.com B5 Vs. B20 Biodiesel: What's The Difference Between These Fuel Types?

Biodiesel is available in several blends, with the most common ones being B5 and B20. The numbers indicate what sets these two fuel types apart.

Скрыть анонс
11.07.2026
22:37 MedicalXpress.com How AI accelerates radiopharmaceutical drug discovery, optimizes personalized dosimetry

A feature News and Perspectives story on technological advances in oncology was published in Journal of Medical Internet Research. Authored by JMIR Correspondent Benedette Cuffari, "AI-Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy" reports on the integration of deep learning and generative AI in radiopharmaceutical medicine, its impact on accelerating drug design, and how personalized dosimetry can improve patient outcomes.

Скрыть анонс
22:23 News-Medical.Net Harvard University hosts the world's largest conference dedicated to longevity biotechnology

The 13th Aging Research & Drug Discovery (ARDD) Meeting, the world's largest conference dedicated to longevity biotechnology, will take place from October 1-3, 2026, at the David Rubenstein Treehouse at Harvard University.

Скрыть анонс
21:30 News-Medical.Net New stem cell approach targets functional cure for diabetes

New research presented today at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an approach that could expand the potential of cell replacement therapy for type 1 diabetes by evaluating whether immune-engineered, allogeneic insulin-producing cells can survive and function without chronic immunosuppression.

Скрыть анонс
21:16 Bioengineer.org Glycocholic Acid Accelerates Colitis by Suppressing Intestinal Stem Cells

A newly identified molecular mechanism reveals how glycocholic acid, a bile acid derivative, accelerates colitis progression by targeting intestinal stem cell renewal—a discovery that could reshape therapeutic approaches for inflammatory bowel diseases. Colitis, characterized by chronic inflammation of the colon, remains a significant clinical challenge with complex underlying molecular pathways. In groundbreaking research published in […]

Скрыть анонс
21:03 SciTechDaily.com Just Two Hours of This Simple Exercise Habit a Week May Help You Live Longer

Lifting weights for about one to two hours a week may support longer life, especially when combined with aerobic activity. A few sets with weights may seem like a small part of a weekly routine, but the effects may reach far beyond stronger arms or a more defined physique. Evidence is increasingly pointing to strength [...]

Скрыть анонс
16:46 News-Medical.Net Insilico Medicine founder to highlight sustainable longevity at BIO Asia-Taiwan

Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, has been invited to attend BIO Asia-Taiwan, which will be held from July 15 to 19 in Taiwan, China.

Скрыть анонс
16:07 Phys.org Saturday Citations: Blue zone longevity; soft tissue find predates dinosaurs; black hole collisions simplified

This week, researchers reported finding nanoplastics in Antarctic soils for the first time, suggesting they were delivered via long-range atmospheric transport. A study associates the use of hormonal birth control with the risk of brain tumors. And researchers developed a new drug against metastatic prostate cancer using human proteins.

Скрыть анонс
14:58 News-Medical.Net New stem cell therapy offers hope for chronic spinal injury

New research presented today at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting highlights a significant step toward developing a stem cell-based treatment for chronic spinal cord injury (SCI), a condition for which no effective restorative therapy currently exists.

Скрыть анонс
04:40 MedicalXpress.com First E-STAR annual report offers unprecedented view of early access to kidney transplantation

Chronic kidney disease affects millions of Americans, and more than 800,000 people in the United States are living with end-stage kidney disease. While kidney transplantation is widely recognized as the preferred treatment for eligible patients, offering longer survival and improved quality of life, many remain on dialysis because of organ shortages and barriers that limit access to all steps in the process of receiving a transplant.

Скрыть анонс
04:32 South China Morning Post How Hong Kong can lead in longevity medicine as silver economy grows

A profound demographic and economic shift is sweeping through Asia, quietly rewriting the rules of national development. The traditional paradigm of treating population ageing as a passive fiscal burden is being dismantled as Beijing makes the “silver economy” and proactive ageing strategies the pillars of national security and economic growth. China’s population aged 60 and above reached 320 million last year, accounting for 23 per cent of its citizenry. This is projected to climb to 400...

Скрыть анонс
03:28 Yahoo.com Business Ocugen Eyes 3 Retinal Gene Therapy Filings as Late-Stage Pipeline Advances

Скрыть анонс
02:18 Bioengineer.org FMR1 Gene Therapy Rescues Fragile X Syndrome Traits in Mice

In a groundbreaking advancement in the treatment of fragile X syndrome (FXS), researchers have successfully deployed gene therapy targeting the FMR1 gene, restoring key neurological and behavioral phenotypes in a mouse model of this debilitating disorder. This milestone study, published in Gene Therapy, offers new hope for addressing the underlying genetic cause of FXS, a […]

Скрыть анонс
10.07.2026
19:38 Nature.Com Lab-grown sperm: scientists inch closer to fertility breakthrough

Скрыть анонс
19:33 Nature.com (news) Lab-grown sperm: scientists inch closer to fertility breakthrough

Скрыть анонс
18:18 MorningAgClips.com Stephen Leblanc to Discuss ‘Ideal’ Cow Longevity During DCRC Webinar

NEW PRAGUE, Minn. — Mark your calendar to attend the July 29 Dairy Cattle Reproduction Council (DCRC) webinar, scheduled to start at 2 p.m. Central time (USA/Canada). University of Guelph’s Stephen LeBlanc will address “Extended lactations and cow longevity: How long is long enough?” This one-hour webinar is free. There are discussions in the dairy […] The post Stephen Leblanc to Discuss ‘Ideal’ Cow Longevity During DCRC Webinar appeared first on Morning Ag Clips.

Скрыть анонс
18:01 Agri-Pulse.com Why Trump’s EO on regenerative agriculture raised red flags across farm country

A passionate debate in the Oval Office between Make America Healthy Again advocates and AFBF President Zippy Duvall generated headlines, but some agricultural leaders contacted by Agri-Pulse say they have additional concerns about a new executive order on regenerative agriculture.

Скрыть анонс
17:28 Bioengineer.org Insilico Medicine to Present Longevity and AI Drug Innovations at BIO Asia-Taiwan 2026

Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, is set to headline BIO Asia-Taiwan 2026, the region’s premier biotechnology conference, with his keynote presentation scheduled for July 15. His address, titled How to Build a Sustainable Longevity Company, promises to shed light on the convergence of longevity science and artificial intelligence, illustrating how these […]

Скрыть анонс
16:12 South China Morning Post US scientists use Chinese humanoid robot to carry out keyhole surgery and remove organs

US scientists have carried out keyhole surgery with a Chinese-made robot taking the place of the lead surgeon. The general-purpose humanoid robot made by Unitree Robotics was remotely controlled by two human surgeons as it successfully removed a pig’s gallbladder at the University of California San Diego (UCSD). Another robot also played a support role during the procedure, controlling the endoscope used to monitor the operation and retracting tissue. “Remotely operated and autonomous humanoid...

Скрыть анонс
15:55 BioTecnika.org New Stem Cell Treatment Fights Diabetes by Fixing the Immune System, Not Just Blood Sugar

Stem Cell Breakthrough Could Reverse Diabetes New therapy repairs the immune system instead of just lowering blood sugar. Patients suffering from Type 1 diabetes have had to live for over a century by receiving injections of insulin to survive. Insulin aids in the regulation of blood sugar levels, but it does not address the fundamental […] The post New Stem Cell Treatment Fights Diabetes by Fixing the Immune System, Not Just Blood Sugar appeared first on BioTecNika.

Скрыть анонс
15:41 MedicalXpress.com Stem cell strategy for chronic spinal cord injury advances

New research presented at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting highlights a significant step toward developing a stem cell-based treatment for chronic spinal cord injury (SCI), a condition for which no effective restorative therapy currently exists.

Скрыть анонс
15:38 ScienceDaily.com Scientists found a longevity diet that helped mice eat more and lose fat

Scientists found that a modified Mediterranean-style diet with low protein and just enough methionine helped mice live healthier lives while reducing body fat and frailty. Human data also linked lower animal protein intake to lower rates of obesity and Type 2 diabetes, suggesting the approach could benefit people as well.

Скрыть анонс
14:35 News-Medical.Net Niche-targeted therapies offer a fresh approach to regenerative medicine

A healthy bone marrow (BM) produces nearly all types of cells in our blood. Many blood disorders occur when hematopoietic stem cells (HSCs) in the BM malfunction.

Скрыть анонс
14:09 Endpts.com The data that led Cellular Intelligence to pick up Novo's Parkinson's stem cell therapy

MONTREAL — After Novo Nordisk closed its cell therapy unit, Cellular Intelligence contracted neurologist and drug developer Nuno Mendonça to conduct due diligence on the Danish pharma’s Parkinson’s cell therapy program. Mendonça said, “He'll do it ...

Скрыть анонс
13:50 N+1 FDA одобрило CRISPR-терапию серповидноклеточной анемии и бета-талассемии с двух лет

FDA одобрило CRISPR-терапию серповидноклеточной анемии и бета-талассемии с двух лет

Скрыть анонс
13:33 Yahoo.com Business Apertura and NIH institutes to test gene therapy for NPC1

Скрыть анонс
13:15 FightAging.org Senescent Cells Contribute to Damage and Dysfunction Following a Heart Attack

Senescent cells are involved in tissue regeneration. Cells enter a senescent state following injury, and in the usual course of events assist in the intricate coordination between immune cells, stem cells, and other cell types that is required to regrow tissue. These senescent cells are then cleared by the immune system. With age, in poorly regenerative tissues, or in severe or persistent injuries, the presence of senescent cells following injury can become excessive and maladaptive. The signaling produced by senescent cells lasts too long, the cells are not cleared, and it causes further harm. As researchers here note, this is what happens following a heart attack, suggesting that there is likely some timing for the delivery of senolytic therapies to selectively destroy the cells become […]

Скрыть анонс
12:18 MorningAgClips.com MDARD Awards Nearly $500,000 to Create Regenerative Farmer Networks Across Michigan

LANSING, Mich. — The Michigan Department of Agriculture and Rural Development (MDARD) has announced nearly $500,000 of grant funding to build 12 regenerative farmer networks that will promote sustainable farming throughout the state.    “Regenerative agriculture gives Michigan farmers practical, scalable tools to manage rising input costs while building healthier soils, improving resiliency and strengthening long-term profitability,” said MDARD Director Tim Boring. […] The post MDARD Awards Nearly $500,000 to Create Regenerative Farmer Networks Across Michigan appeared first on Morning Ag Clips.

Скрыть анонс
09:44 Bioengineer.org First Clinical Trial of Stem Cell Therapy for Huntington’s Disease Announced

A groundbreaking clinical trial has commenced, evaluating a pluripotent stem cell-derived neural stem cell therapy for Huntington’s disease (HD), marking a pivotal advance in regenerative medicine. This Phase 1b/2a study, known as REGEN4HD, was highlighted today at the ISSCR 2026 Annual Meeting, signaling the first-ever human trial of its kind targeting this devastating neurodegenerative disorder. […]

Скрыть анонс
09:16 Bioengineer.org Stem Cell Therapy Shows One-Year Survival in Retinitis Pigmentosa Patients

At ISSCR 2026, groundbreaking clinical data revealed the long-term survival of human neural progenitor cells transplanted into patients with retinitis pigmentosa (RP), marking a pivotal advance in retinal disease research. The study demonstrated that CNS10-NPC cells, derived from fetal brain cortex, survived in the subretinal space for at least one year without significant safety concerns, […]

Скрыть анонс
09:04 Bioengineer.org Long-Term Stem Cell Data Boosts Chronic Stroke Recovery Research

Long-term Clinical Data Unveil Promise of iPSC-Derived Neural Progenitor Cells in Chronic Stroke Recovery In a breakthrough presentation at the ISSCR 2026 Annual Meeting, researchers disclosed previously unpublished long-term clinical and imaging data on hNPC01, an induced pluripotent stem cell (iPSC)-derived forebrain neural progenitor cell therapy designed to treat chronic ischemic stroke. This Phase I […]

Скрыть анонс
08:51 Arxiv.org Physics TeV Electron Beams from Plasma Acceleration via Regenerative Cascading

arXiv:2607.07979v1 Announce Type: new Abstract: Plasma accelerators sustain gradients orders of magnitude higher than conventional radiofrequency machines, but most proposed paths to TeV energies still require tens of stages, each demanding sub-micrometer alignment, femtosecond synchronization, and precise matching of the accelerating trailing bunch. Here we introduce plasma wakefield acceleration via regenerative cascading, in which each stage self-injects a fresh trailing electron bunch and the accelerated trailing bunch becomes the driver for the next stage. This approach has several advantages: energy multiplication instead of addition; automatic alignment, synchronization, and matching of the trailing bunch to the wake; and trailing bunch brightness reset in each stage. Particle-in-cell simulations show the generation of a 1.1 TeV electron beam with ~0.3% rms energy spread and 0.12 nC charge from a two-stage, sub-kilometer plasma accelerator driven by a 45 GeV, 100 nC beam. The

Скрыть анонс
08:38 Arxiv.org CS Track2Map: Online Deformable SLAM with Motion-Aware Pose Optimization in Robotic Surgery

arXiv:2607.08408v1 Announce Type: new Abstract: Gaussian splatting is the current state-of-the-art for dense, deformable 3D anatomy reconstruction in robot-assisted minimally invasive surgery (RAMIS); however, most pipelines are offline and depend on accurate camera trajectory priors (often from robotic kinematics), limiting applicability when priors are missing or noisy. To address these limitations, we propose Track2Map, an online 3D Gaussian Splatting pipeline that jointly optimizes camera trajectory and 3D deformable scene representation directly from surgical video. Track2Map is therefore capable of robust 3D reconstructions when camera trajectory priors are either absent or noisy, and due to its online nature it effectively works as a Simultaneous Localisation and Mapping (SLAM) method. To stabilize optimization in the presence of tissue motion and ambiguous visual cues, we introduce a track-anchored deformation initialization using dense 2D point tracks. Track statistics are

Скрыть анонс
08:38 Arxiv.org CS A safety-oriented hypothetico-deductive framework for AI-assisted differential diagnosis

arXiv:2607.08038v1 Announce Type: new Abstract: Diagnostic error is a major threat to patient safety, yet current large language model (LLM) systems often treat diagnosis as a one-shot prediction task, lacking safeguards against missed high-risk alternatives or rigorous verification of their reasoning. Here, we present AegisDx, a safety-oriented framework for hypothetico-deductive clinical reasoning. AegisDx coordinates specialized LLM components through role-specific contracts, structured intermediate outputs, evidence-retrieval interfaces, and verification gates to generate broad differential diagnoses, enforce explicit screening for dangerous "must-not-miss" conditions, verify reasoning against grounded medical evidence, and structure actionable next steps. We evaluated AegisDx across three layers. On literature-derived case reports from NEJM and JAMA, with GPT-oss-120B as the shared backbone, Top-3 diagnostic accuracy was 59.9% versus 52.1% for the standalone LLM on JAMA cases and

Скрыть анонс
08:38 Arxiv.org CS In vivo feasibility study of humanoid robots in surgery

arXiv:2607.07972v1 Announce Type: new Abstract: Recent advances in actuation, control and learning have rapidly pushed humanoid robots from a distant vision towards near-term real-world deployment. Healthcare is a particularly pressing domain, in which staffing shortages and increasing care demand are widening the gap between clinical workload and available skilled labour. Although current automation has largely focused on digital and logistical tasks, much hospital work remains embodied, requiring mobility, manipulation and safe interaction in human-designed environments. Humanoid form factors offer unique potential, particularly for assisting with surgical tasks. Traditionally, robotic systems for surgery are purpose-built platforms such as Intuitive Surgical's da Vinci Surgical System, and it remains unclear how close current humanoid systems are to meeting the precision, control and safety requirements of minimally invasive surgery. Here we present a systematic evaluation of

Скрыть анонс
08:38 Arxiv.org CS Aligning Clinical Needs and AI Capabilities: A Survey on LLMs for Medical Reasoning

arXiv:2607.07761v1 Announce Type: new Abstract: Large language models (LLMs) have emerged as important tools in healthcare, showing growing potential for clinical reasoning and patient care. This survey examines recent progress in medical LLMs, focusing on reasoning applications and requirements. We present a dual-view approach that connects clinical practice with computational methods. On the clinical side, we establish a five-level competency scheme following Miller's Pyramid, progressing from knowledge recall to dynamic case management. On the computational side, we link deductive, inductive, and abductive reasoning patterns to common medical goals and tasks. We also introduce a benchmark dataset spanning five levels of medical reasoning capability and report results on 18 state-of-the-art models, revealing that medical specialist models excel in diagnosis-centric tasks while general models lead in decision support and dialogue. We conclude by discussing current progress and open

Скрыть анонс
06:50 News-Medical.Net Transplanted neural progenitor cells survive one year in patients with retinitis pigmentosa

New, previously unpublished clinical data was presented today at ISSCR 2026 demonstrating that transplanted human neural progenitor cells survived for at least one year following subretinal transplantation in patients with retinitis pigmentosa (RP), while maintaining a favorable safety profile.

Скрыть анонс
06:37 News-Medical.Net Stem cell-derived dopaminergic cell transplantation shows encouraging results for Parkinson's disease

The International Society for Stem Cell Research (ISSCR) today announced the presentation of new clinical data from the STEM-PD Phase I/II clinical trial at the ISSCR 2026 Annual Meeting.

Скрыть анонс
02:31 Yahoo.com Business He founded Udemy and Carbon Health. Now's he's tackling AI.

Скрыть анонс
01:45 MedicalXpress.com New genetic switch could improve gene therapy for drug-resistant epilepsy

Epilepsy affects more than 50 million people worldwide, making it one of the most common neurological disorders. Although medication helps many patients achieve seizure control, approximately one-third continue to experience seizures despite treatment. Seizures often arise when the brain's excitation-inhibition (E/I) balance breaks down. In healthy conditions, specialized inhibitory neurons act as a natural braking system, releasing a neurotransmitter called gamma-aminobutyric acid (GABA) that helps prevent excessive electrical activity. When this inhibitory control is weakened, abnormal bursts of activity can spread through the brain and trigger seizures.

Скрыть анонс
01:41 GenEngNews.com Stem Cell Therapy Shows Promise in First Human Parkinson’s Disease Trial

One year findings from Phase I/II clinical study support the feasibility of transplanting stem-cell derived dopamine progenitor cells into the brain of Parkinson’s disease patients. The post Stem Cell Therapy Shows Promise in First Human Parkinson’s Disease Trial appeared first on GEN - Genetic Engineering and Biotechnology News.

Скрыть анонс
01:19 Cnet.com Google Health Finally Recognizes the Value of Naps

A 20-minute nap will count toward your daily sleep total. But is a quick power nap worth it?

Скрыть анонс
00:54 MedicalDaily.com The U.S. Military Just Deployed AI That Listens to Doctor Visits and Writes the Medical Notes

The U.S. Military Health System is deploying AI that listens to clinical visits and auto-generates medical notes worldwide. Consent is required. Here's how it works.

Скрыть анонс
00:52 Bioengineer.org Caloric Restriction Enhances Blood Sugar Control Through Adiponectin–Ceramide Pathway

Caloric Restriction Unveils New Mechanism for Improved Glycemic Control in Non-Obese Adults In a groundbreaking study published in Nature Communications, researchers have uncovered a critical biological pathway through which caloric restriction enhances glycemic control in non-obese men and women. The findings shed light on the role of the adiponectin–ceramide axis, providing new insights into metabolic […]

Скрыть анонс
00:24 Bioengineer.org Doctors struggle to learn from experiences that challenge AI recommendations

Physicians Struggle to Detect AI Errors in Clinical Decision-Making, Study Finds Artificial intelligence (AI) holds promise for transforming healthcare by assisting physicians in patient classification and treatment decisions. However, new research from the University of the Basque Country in Spain reveals a troubling trend: physicians often over-trust AI recommendations, even when presented with contradictory clinical […]

Скрыть анонс
00:11 Bioengineer.org Genome Editing in Rats Advances Accurate ER+ Breast Cancer Models

In a groundbreaking advancement for cancer research, scientists at Baylor College of Medicine have developed an innovative approach to modeling estrogen receptor-positive (ER+) breast cancer using genetically engineered rats. This novel technique leverages modified somatic genome editing tools based on the CRISPR-Cas9 system, enabling precise oncogene alterations that lead to authentic tumor formation resembling human […]

Скрыть анонс
09.07.2026
23:31 MedicalXpress.com Genome editing in rats enables more accurate estrogen receptor-positive breast cancer models

Rat disease models have played an integral role in scientific discovery and cancer research, including Nobel Prize–winning work from Charles Huggins on hormone therapy for prostate cancer in 1966. However, technical challenges in genetic engineering of rat models have limited their use in research, and over the decades, mouse models have become much more widely used.

Скрыть анонс
23:11 Politico.com The tricky business of AI cloning

Скрыть анонс
23:05 Bioengineer.org Unraveling Human Cell Fate to Create Stem Cell-Derived Islets

In a groundbreaking advance for diabetes research, scientists have unveiled new insights into the cellular decisions that govern the formation of human pancreatic islets—the clusters of cells responsible for regulating blood sugar. This study brings long-sought clarity to how stem cells differentiate into either α (alpha) or β (beta) cells, a key puzzle in creating […]

Скрыть анонс
22:24 Endpts.com ARPA-H bookmarks $160M for custom gene editing treatments. Is it enough?

After an infant last year was saved from a deadly disease thanks to a bespoke gene editing therapy that fixed an incredibly rare mutation in his DNA, the US government is hoping ...

Скрыть анонс
22:24 News-Medical.Net AI-powered digital twins help train future mental health clinicians

Researchers from the University of Pennsylvania, New York University and Penn's Linguistic Data Consortium have received a two-year, $4 million grant from the Wellcome Trust to develop a scalable, AI-powered platform for training mental health clinicians.

Скрыть анонс
21:58 News-Medical.Net Stem cell study uncovers molecular pathway for enamel regeneration

Tooth enamel is the hardest substance in the human body, yet once damaged, it cannot regenerate naturally.

Скрыть анонс
21:31 Healio.com FDA clears AI-powered screening software for diabetic retinopathy

Editor’s note: This is a developing news story. Please check back soon for updates.The FDA granted 510(k) clearance for iPredict-DR, an AI-powered screening software designed to detect more than mild diabetic retinopathy in adults with diabetes, according to a press release from iHealthScreen.The clearance was supported by data from a clinical validation trial that looked at “diagnostic performance, safety and usability.” The software uses AI to examine color retinal fundus images taken with an iCare DRSplus camera, which is designed to be operable by minimally skilled health care workers.

Скрыть анонс
21:29 News-Medical.Net Review highlights macrophages as key drivers of chronic transplant rejection

A comprehensive review led by Professors Malgorzata Kloc and Xian Chang Li at the Immunobiology and Transplant Science Center of Houston Methodist Hospital in the United States was published in Volume 2, article number 29 of the journal Immunity & Inflammation on June 30, 2026.

Скрыть анонс
21:01 MedicalXpress.com New study highlights potential challenges for using automated AI tools in health care

In experiments in which physicians made decisions about treating hypothetical patients, the physicians tended to trust incorrect advice presented as being generated by artificial intelligence (AI), even after being given the opportunity to notice that patient recovery data contradicted the recommendations. Aranzazu Vinas of the University of the Basque Country, Spain, and colleagues present these findings in the open-access journal PLOS Digital Health.

Скрыть анонс
20:47 News-Medical.Net Clinical trial finds stem cell brain transplants feasible for Parkinson's disease

A landmark study led from Lund, Sweden, has shown that transplanting stem-cell derived dopamine progenitor cells into the brain is feasible.

Скрыть анонс
20:47 News-Medical.Net First clinical trial evaluates stem cell therapy for Huntington's disease

An update on the first clinical trial evaluating a pluripotent stem cell-derived neural stem cell therapy for Huntington's disease was presented today at the ISSCR 2026 Annual Meeting.

Скрыть анонс
19:57 TheNextWeb.com A startup just 3D-printed kidney and liver tissue in space, a first

Auxilium Biotechnologies has bioprinted kidney and liver tissue aboard the International Space Station. It says that is the first time anyone has made either in space. The samples flew home last month on a SpaceX cargo capsule, and the company announced the results on Thursday. It was not a one-off. In the same mission, Auxilium’s […] This story continues at The Next Web

Скрыть анонс
18:28 Bioengineer.org New Stem Cell Therapy Shows Promise for Parkinson’s at ISSCR 2026

At the forefront of regenerative medicine, new clinical data presented at the ISSCR 2026 Annual Meeting spotlight a promising stem cell-based therapy targeting Parkinson’s disease. The STEM-PD Phase I/II clinical trial assessed a cryopreserved, off-the-shelf dopaminergic progenitor cell product derived from human pluripotent stem cells. This innovative approach aims to replace the dopamine-producing neurons lost […]

Скрыть анонс
18:01 Healio.com Decoding the evidence on peptides, from topicals to longevity

Few molecules in medicine generate as much excitement — and as much noise — as peptides.Walk into any medical spa, open any luxury skin care brand’s website or scroll through a longevity-focused biohacking forum and you will find peptides promised as the solution to wrinkles, muscle loss, metabolic dysfunction and aging itself. What you will find far less frequently is a rigorous accounting of what the evidence actually supports.As a dermatologist-scientist, I am constantly asked about peptides — by patients shopping for serums, by colleagues curious about injectables and increasingly by

Скрыть анонс
17:47 Healio.com Amniotic membrane transplantation a versatile tool

Amniotic membrane has been in clinical use in ophthalmology for more than half a century. The histological nature of the membrane has been used for various eye surface diseases, and indications have expanded.Amniotic membrane (AM) is the innermost layer of the placenta and consists of a thick basement membrane and an avascular stromal matrix. Since its first ophthalmic use in the 1940s and its reintroduction by Tseng and colleagues in the 1990s, amniotic membrane transplantation (AMT) has become an important tool in ocular surface reconstruction.AM is composed of five layers: epithelial

Скрыть анонс
17:46 Bioengineer.org CRISPR Advances Transform Cancer Diagnosis and Treatment in Clinical Oncology

CRISPR Technologies Propel Cancer Care into a New Era of Precision Medicine Cancer treatment is undergoing a profound transformation as molecular classification reshapes therapeutic strategies. Yet, despite advances, many pivotal oncogenic drivers remain elusive drug targets, and the shadow of both intrinsic and acquired resistance curtails long-term clinical success. Emerging from the crucible of experimental […]

Скрыть анонс
17:46 MedicalXpress.com AI can't replace mental health therapists. But here's where it might make a difference

A person wakes in the middle of the night, overwhelmed and needing someone to talk to. But instead of calling a loved one or booking a counseling session, they open ChatGPT.

Скрыть анонс
17:19 Cnet.com I Tested AI to Find Errors in My Medical Bills. Here’s What It Found

Using ChatGPT to audit my complex health insurance claims was a massive undertaking -- but it confirmed a hidden $1,512 overpayment.

Скрыть анонс
17:03 MedicalXpress.com FDA expands use of first sickle cell disease gene therapy for children as young as 2 years

The U.S. Food and Drug Administration has issued a supplemental approval for Casgevy (exagamglogene autotemcel) for patients ages 2 and older with either sickle cell disease (SCD) with recurrent vaso-occlusive crises (VOCs) or transfusion-dependent β thalassemia (TDT). Supplemental approval was granted to Vertex Pharmaceuticals.

Скрыть анонс
16:07 Google news Health New Google Health App Update 5.03: More Metrics, Sleep Improvements - Droid Life

New Google Health App Update 5.03: More Metrics, Sleep Improvements  Droid LifeGoogle Health is making it easier to see more of your favorite metrics at a glance  Android AuthorityGoogle Health update improves naps and the Today tab  Gadgets & WearablesGoogle Health's latest update closes another Fitbit gap  Android PoliceGoogle Health v5.03 Release Notes Released  jetstream.blog

Скрыть анонс
16:07 Google news Sci/Tech New Google Health App Update 5.03: More Metrics, Sleep Improvements - Droid Life

New Google Health App Update 5.03: More Metrics, Sleep Improvements  Droid LifeGoogle Health is making it easier to see more of your favorite metrics at a glance  Android AuthorityGoogle Health update improves naps and the Today tab  Gadgets & WearablesGoogle Health's latest update closes another Fitbit gap  Android PoliceGoogle Health v5.03 Release Notes Released  jetstream.blog

Скрыть анонс
15:38 MedicalXpress.com Data highlight progress toward personalized stem cell therapy for Parkinson's disease

Interim clinical findings from the first Phase I/IIa trial using autologous-induced pluripotent stem cell (iPSC)-derived dopamine neuron precursor cells, along with the novel quality-control tools developed to manufacture these individualized therapies, have been presented by Jeanne Loring, Ph.D., Scripps Research, U.S., at the ISSCR 2026 Annual Meeting.

Скрыть анонс
15:38 MedicalXpress.com Long-term stroke data reveal stem cell therapy's safety, biological activity over years

Previously unpublished long-term clinical and imaging findings from participants treated with an induced pluripotent stem cell (iPSC)-derived neural progenitor cell therapy for chronic ischemic stroke were presented at the ISSCR 2026 Annual Meeting.

Скрыть анонс
15:38 MedicalXpress.com New clinical data advances stem cell-based cell therapy for Parkinson's disease

New clinical data from the STEM-PD Phase I/II clinical trial have been presented at the ISSCR 2026 Annual Meeting. The study reports 12-month outcomes evaluating a cryopreserved, off-the-shelf dopaminergic progenitor cell product derived from human pluripotent stem cells for the treatment of Parkinson's disease.

Скрыть анонс
15:38 MedicalXpress.com Data demonstrate 1-year survival of stem cell-derived neural progenitor cells in patients with retinitis pigmentosa

New, previously unpublished clinical data have been presented at ISSCR 2026 demonstrating that transplanted human neural progenitor cells survived for at least one year following subretinal transplantation in patients with retinitis pigmentosa (RP), while maintaining a favorable safety profile.

Скрыть анонс
15:38 MedicalXpress.com Huntington's treatment quest reaches first pluripotent stem cell trial, with safety now under review

An update on the first clinical trial evaluating a pluripotent stem cell-derived neural stem cell therapy for Huntington's disease was presented at the ISSCR 2026 Annual Meeting. The Phase Ib/IIa REGEN4HD study represents a significant translational milestone following years of preclinical research, pivotal safety studies, regulatory engagement and clinical trial development.

Скрыть анонс
15:24 Bioengineer.org Epitope Editing Enables Safe Transplantation and In Vivo Cell Selection

Researchers have identified specific KIT receptor mutations that enable resistance to the stem cell factor (SCF)-antagonistic antibody SR-1, offering a promising pathway for non-genotoxic conditioning in hematopoietic stem cell transplantation. This breakthrough could significantly enhance the eradication of host hematopoiesis while preserving critical receptor functions. SR-1, a monoclonal antibody targeting KIT, blocks binding of its […]

Скрыть анонс
15:24 MedicalXpress.com Medical AI may look less biased on paper but not in practice, new study finds

Large language models (LLMs) are only as good as the data they learn from. If their training data contains social biases, the models may unintentionally repeat those biases in their responses. As their use increases with the rise of generative AI, it has become evident that they contain biases that reinforce stereotypes based on factors like ethnicity, gender or geography. This is concerning because LLM-based chatbots have become an integral part of the health care system, where health-related stigma can negatively affect one's diagnosis and care.

Скрыть анонс
Первая← Предыдущая12345678910Предыдущая →